DNAJA1 and acute lymphoblastic leukemia: For example, HDJ-2 (DNAJA1), due to its high expression in B-lineage acute lymphoblastic leukemia (ALL) cells, has been specifically used as a diagnostic biomarker to detect minimal residual disease [65].